British aneurysm nimodipine trial reported improved clinical outcome with nimodipineBMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7001.388c (Published 05 August 1995) Cite this as: BMJ 1995;311:388
- Gordon D Murray, Director
- Robertson Centre for Biostatistics, University of Glasgow, Glasgow G12 8QQ
EDITOR,--L E Wagenknecht and colleagues report a randomised placebo controlled trial, in which the calcium antagonist nimodipine was assessed as a possible neuroprotective agent during cardiac surgery.1 The trial was stopped prematurely after 149 patients had been enrolled because an interim analsis showed an excess mortality with nimodipine (eight deaths versus one). This excess mortality was strongly associated with major surgical …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial